Neuroproteomics and Artificial Intelligence in Neurological Disorders: Current Advances in Biomarker Discovery
Preprint
- 9 July 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Proteomics has emerged as a powerful tool for advancing our understanding of brain disorders by enabling large-scale characterization of protein expression, post-translational modifications, and interaction networks. Neurological conditions are often characterized by complex and dynamic molecular changes that are not fully captured by traditional diagnostic approaches. Proteomic technologies, particularly mass spectrometry-based and affinity-based methods, offer the ability to identify disease-specific protein signatures and elucidate underlying pathophysiological mechanisms, including neurodegeneration, neurodevelopment and neuroinflammation and alterations happening to the extracellular matrix and body fluid homeostasis. In recent years, artificial intelligence has emerged as a powerful complement to proteomics, enabling improved analysis of complex biological datasets. This integration has significantly enhanced the discovery of biomarkers for early diagnosis, disease stratification, and monitoring of therapeutic responses. Thus, cerebrospinal fluid and blood-based proteomic analyses have revealed promising candidates for neurological diseases. However, challenges remain in terms of reproducibility, standardization, and clinical validation. This review summarizes current advances in proteomics across a range of brain disorders, highlighting key molecular pathways, biomarker discovery efforts, and evolving clinical applications. Furthermore, it discusses ongoing limitations and outlines future directions, including the application of machine learning for improved biomarker identification and precision medicine.Keywords
All Related Versions
This publication has 116 references indexed in Scilit:
- Artificial Intelligence in Autism Spectrum Disorder Diagnosis: A Scoping Review of Face, Voice, and Text Analysis MethodsHealth Science Reports, 2025
- Recent Advances in Human Cerebrospinal Fluid Proteomics2025
- A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneityMedcomm, 2023
- iTRAQ‐Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with AutismProteomics – Clinical Applications, 2017
- Expression and oxidative modifications of plasma proteins in autism spectrum disorders: Interplay between inflammatory response and lipid peroxidationProteomics – Clinical Applications, 2016
- Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience, 2009
- Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseaseProteomics – Clinical Applications, 2008
- Proteomic analysis of cerebrospinal fluid from multiple sclerosis patientsProteomics, 2004
- A novel experimental design for comparative two‐dimensional gel analysis: Two‐dimensional difference gel electrophoresis incorporating a pooled internal standardProteomics, 2003
- Difference gel electrophoresis. A single gel method for detecting changes in protein extractsElectrophoresis, 1997